Endogenous prostaglandins modulate lipolytic processes in adipose tissue.
D000085:Acetates / Q000494:pharmacology; D000273:Adipose Tissue / Q000032:analysis / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D000242:Cyclic AMP / Q000032:analysis / Q000494:pharmacology; D003517:Cyclopentanes / Q000494:pharmacology; D003989:Dibenzoxazepines / Q000494:pharmacology; D003998:Dicarboxylic Acids / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005227:Fatty Acids / Q000494:pharmacology; D006834:Hydrazines / Q000494:pharmacology; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D050356:Lipid Metabolism; D011448:Prostaglandin Antagonists; D011453:Prostaglandins / Q000494:pharmacology / Q000502:physiology*; D051381:Rats; D013806:Theophylline / Q000494:pharmacology
D000085:Acetates; D003517:Cyclopentanes; D003989:Dibenzoxazepines; D003998:Dicarboxylic Acids; D005227:Fatty Acids; D006834:Hydrazines; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D000324:Adrenocorticotropic Hormone; D013806:Theophylline; D000242:Cyclic AMP; D001241:Aspirin; D007213:Indomethacin; D004837:Epinephrine